| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 307.622.710 $ | 99,92 | 17.980.740 | |||||||
| Enliven Therapeutics Inc | Enliven Therapeutics Inc | EC | 29337E102 | Long | Börsenkurs (Stufe 1) | 7.538.042 $ | 2,45 | 192.297 | |
| Corcept Therapeutics Inc | Corcept Therapeutics Inc | EC | 218352102 | Long | Börsenkurs (Stufe 1) | 7.053.081 $ | 2,29 | 174.971 | |
| Terns Pharmaceuticals Inc | Terns Pharmaceuticals Inc | EC | 880881107 | Long | Börsenkurs (Stufe 1) | 6.653.106 $ | 2,16 | 126.197 | |
| Perrigo Co PLC | Perrigo Co PLC | EC | IE00BGH1M568 | Long | Börsenkurs (Stufe 1) | 6.463.171 $ | 2,10 | 601.785 | |
| Axsome Therapeutics Inc | Axsome Therapeutics Inc | EC | 05464T104 | Long | Börsenkurs (Stufe 1) | 6.255.937 $ | 2,03 | 37.013 | |
| Innoviva Inc | Innoviva Inc | EC | 45781M101 | Long | Börsenkurs (Stufe 1) | 6.135.216 $ | 1,99 | 263.314 | |
| Merck & Co Inc | Merck & Co Inc | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 6.110.732 $ | 1,98 | 50.800 | |
| Pfizer Inc | Pfizer Inc | EC | 717081103 | Long | Börsenkurs (Stufe 1) | 6.072.216 $ | 1,97 | 216.247 | |
| Royalty Pharma PLC | Royalty Pharma PLC | EC | GB00BMVP7Y09 | Long | Börsenkurs (Stufe 1) | 6.065.375 $ | 1,97 | 126.441 | |
| Elanco Animal Health Inc | Elanco Animal Health Inc | EC | 28414H103 | Long | Börsenkurs (Stufe 1) | 6.024.354 $ | 1,96 | 251.749 | |
| Jazz Pharmaceuticals PLC | Jazz Pharmaceuticals PLC | EC | IE00B4Q5ZN47 | Long | Börsenkurs (Stufe 1) | 6.018.974 $ | 1,96 | 31.838 | |
| Esperion Therapeutics Inc | Esperion Therapeutics Inc | EC | 29664W105 | Long | Börsenkurs (Stufe 1) | 6.013.752 $ | 1,95 | 2.194.800 | |
| Edgewise Therapeutics Inc | Edgewise Therapeutics Inc | EC | 28036F105 | Long | Börsenkurs (Stufe 1) | 6.000.656 $ | 1,95 | 190.497 | |
| MBX Biosciences Inc | MBX Biosciences Inc | EC | 55287L101 | Long | Börsenkurs (Stufe 1) | 5.992.208 $ | 1,95 | 200.744 | |
| Definium Therapeutics Inc | Definium Therapeutics Inc | EC | 24477V105 | Long | Börsenkurs (Stufe 1) | 5.989.070 $ | 1,95 | 316.882 | |
| Bristol-Myers Squibb Co | Bristol-Myers Squibb Co | EC | 110122108 | Long | Börsenkurs (Stufe 1) | 5.969.476 $ | 1,94 | 98.425 | |
| ANI Pharmaceuticals Inc | ANI Pharmaceuticals Inc | EC | 00182C103 | Long | Börsenkurs (Stufe 1) | 5.950.676 $ | 1,93 | 77.382 | |
| Johnson & Johnson | Johnson & Johnson | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 5.938.670 $ | 1,93 | 24.295 | |
| Tarsus Pharmaceuticals Inc | Tarsus Pharmaceuticals Inc | EC | 87650L103 | Long | Börsenkurs (Stufe 1) | 5.926.342 $ | 1,92 | 84.481 | |
| Trevi Therapeutics Inc | Trevi Therapeutics Inc | EC | 89532M101 | Long | Börsenkurs (Stufe 1) | 5.898.574 $ | 1,92 | 494.432 | |
| Pacira BioSciences Inc | Pacira BioSciences Inc | EC | 695127100 | Long | Börsenkurs (Stufe 1) | 5.844.044 $ | 1,90 | 258.586 | |
| Zoetis Inc | Zoetis Inc | EC | 98978V103 | Long | Börsenkurs (Stufe 1) | 5.825.625 $ | 1,89 | 49.282 | |
| Crinetics Pharmaceuticals Inc | Crinetics Pharmaceuticals Inc | EC | 22663K107 | Long | Börsenkurs (Stufe 1) | 5.798.197 $ | 1,88 | 159.642 | |
| Nektar Therapeutics | Nektar Therapeutics | EC | 640268306 | Long | Börsenkurs (Stufe 1) | 5.792.407 $ | 1,88 | 80.506 | |
| Liquidia Corp | Liquidia Corp | EC | 53635D202 | Long | Börsenkurs (Stufe 1) | 5.777.956 $ | 1,88 | 153.099 | |
| Amneal Pharmaceuticals Inc | Amneal Pharmaceuticals Inc | EC | 03168L105 | Long | Börsenkurs (Stufe 1) | 5.773.449 $ | 1,88 | 464.477 | |
| Harmony Biosciences Holdings Inc | Harmony Biosciences Holdings Inc | EC | 413197104 | Long | Börsenkurs (Stufe 1) | 5.743.563 $ | 1,87 | 205.054 | |
| Supernus Pharmaceuticals Inc | Supernus Pharmaceuticals Inc | EC | 868459108 | Long | Börsenkurs (Stufe 1) | 5.733.765 $ | 1,86 | 110.926 | |
| Viatris Inc | Viatris Inc | EC | 92556V106 | Long | Börsenkurs (Stufe 1) | 5.709.123 $ | 1,85 | 422.585 | |
| Xeris Biopharma Holdings Inc | Xeris Biopharma Holdings Inc | EC | 98422E103 | Long | Börsenkurs (Stufe 1) | 5.658.764 $ | 1,84 | 975.649 | |
| Harrow Inc | Harrow Inc | EC | 415858109 | Long | Börsenkurs (Stufe 1) | 5.635.006 $ | 1,83 | 159.813 | |
| Organon & Co | Organon & Co | EC | 68622V106 | Long | Börsenkurs (Stufe 1) | 5.525.314 $ | 1,79 | 922.423 | |
| Nuvation Bio Inc | Nuvation Bio Inc | EC | 67080N101 | Long | Börsenkurs (Stufe 1) | 5.517.661 $ | 1,79 | 1.286.168 | |
| Phibro Animal Health Corp | Phibro Animal Health Corp | EC | 71742Q106 | Long | Börsenkurs (Stufe 1) | 5.510.259 $ | 1,79 | 99.625 | |
| Amylyx Pharmaceuticals Inc | Amylyx Pharmaceuticals Inc | EC | 03237H101 | Long | Börsenkurs (Stufe 1) | 5.496.241 $ | 1,79 | 395.413 | |
| Indivior Pharmaceuticals Inc | Indivior Pharmaceuticals Inc | EC | 45579U109 | Long | Börsenkurs (Stufe 1) | 5.480.944 $ | 1,78 | 179.821 | |
| Collegium Pharmaceutical Inc | Collegium Pharmaceutical Inc | EC | 19459J104 | Long | Börsenkurs (Stufe 1) | 5.480.890 $ | 1,78 | 165.736 | |
| Eli Lilly & Co | Eli Lilly & Co | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 5.430.322 $ | 1,76 | 5.904 | |
| Prestige Consumer Healthcare Inc | Prestige Consumer Healthcare Inc | EC | 74112D101 | Long | Börsenkurs (Stufe 1) | 5.398.845 $ | 1,75 | 91.089 | |
| Ligand Pharmaceuticals Inc | Ligand Pharmaceuticals Inc | EC | 53220K504 | Long | Börsenkurs (Stufe 1) | 5.327.461 $ | 1,73 | 26.684 | |
| Ocular Therapeutix Inc | Ocular Therapeutix Inc | EC | 67576A100 | Long | Börsenkurs (Stufe 1) | 5.263.453 $ | 1,71 | 621.423 | |
| Omeros Corp | Omeros Corp | EC | 682143102 | Long | Börsenkurs (Stufe 1) | 5.225.574 $ | 1,70 | 494.846 | |
| EyePoint Inc | EyePoint Inc | EC | 30233G209 | Long | Börsenkurs (Stufe 1) | 5.100.277 $ | 1,66 | 395.677 | |
| Alumis Inc | Alumis Inc | EC | 022307102 | Long | Börsenkurs (Stufe 1) | 4.937.518 $ | 1,60 | 224.127 | |
| Amphastar Pharmaceuticals Inc | Amphastar Pharmaceuticals Inc | EC | 03209R103 | Long | Börsenkurs (Stufe 1) | 4.460.271 $ | 1,45 | 227.681 | |
| Phathom Pharmaceuticals Inc | Phathom Pharmaceuticals Inc | EC | 71722W107 | Long | Börsenkurs (Stufe 1) | 4.431.790 $ | 1,44 | 398.901 | |
| Theravance Biopharma Inc | Theravance Biopharma Inc | EC | KYG8807B1068 | Long | Börsenkurs (Stufe 1) | 4.362.867 $ | 1,42 | 268.815 | |
| Rapport Therapeutics Inc | Rapport Therapeutics Inc | EC | 75383L102 | Long | Börsenkurs (Stufe 1) | 4.208.630 $ | 1,37 | 134.504 | |
| Arvinas Inc | Arvinas Inc | EC | 04335A105 | Long | Börsenkurs (Stufe 1) | 3.837.974 $ | 1,25 | 362.073 | |
| CorMedix Inc | CorMedix Inc | EC | 21900C308 | Long | Börsenkurs (Stufe 1) | 3.763.745 $ | 1,22 | 554.307 | |
| BioAge Labs Inc | BioAge Labs Inc | EC | 09077V100 | Long | Börsenkurs (Stufe 1) | 3.689.935 $ | 1,20 | 210.974 | |
| Maze Therapeutics Inc | Maze Therapeutics Inc | EC | 578784100 | Long | Börsenkurs (Stufe 1) | 3.493.674 $ | 1,13 | 117.041 | |
| Septerna Inc | Septerna Inc | EC | 81734D104 | Long | Börsenkurs (Stufe 1) | 3.091.051 $ | 1,00 | 128.633 | |
| WaVe Life Sciences Ltd | WaVe Life Sciences Ltd | EC | SG9999014716 | Long | Börsenkurs (Stufe 1) | 3.039.802 $ | 0,99 | 419.283 | |
| Zevra Therapeutics Inc | Zevra Therapeutics Inc | EC | 488445206 | Long | Börsenkurs (Stufe 1) | 3.027.798 $ | 0,98 | 324.871 | |
| Fulcrum Therapeutics Inc | Fulcrum Therapeutics Inc | EC | 359616109 | Long | Börsenkurs (Stufe 1) | 2.820.389 $ | 0,92 | 367.717 | |
| Aquestive Therapeutics Inc | Aquestive Therapeutics Inc | EC | 03843E104 | Long | Börsenkurs (Stufe 1) | 2.491.266 $ | 0,81 | 600.305 | |
| LB Pharmaceuticals Inc | LB Pharmaceuticals Inc | EC | 50180M108 | Long | Börsenkurs (Stufe 1) | 2.199.721 $ | 0,71 | 89.202 | |
| Alto Neuroscience Inc | Alto Neuroscience Inc | EC | 02157Q109 | Long | Börsenkurs (Stufe 1) | 1.647.514 $ | 0,54 | 73.288 | |
| 307.622.710 $ | 99,92 | 17.980.740 |